검색
Unicycive Therapeutics Inc
UNCY관심 목록에 추가
5.010USD
-0.290-5.47%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
126.44M시가총액
손실P/E TTM
자세한 내용은 Unicycive Therapeutics Inc 회사
Unicycive Therapeutics, Inc. is a biotechnology company developing treatments for kidney diseases. The Company's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Unicycive Therapeutics Inc 정보
종목 코드 UNCY
회사 이름Unicycive Therapeutics Inc
상장일Jun 17, 2021
CEOGupta (Shalabh)
직원 수22
유형Ordinary Share
회계 연도 종료Jun 17
주소4300 El Camino Real, Suite 210
도시LOS ALTOS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94022
전화16503840642
웹사이트https://unicycive.com/
종목 코드 UNCY
상장일Jun 17, 2021
CEOGupta (Shalabh)
Unicycive Therapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
Mr. Doug Jermasek
Mr. Doug Jermasek
Executive Vice President - Corporate Strategy
Executive Vice President - Corporate Strategy
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
자주 묻는 질문
Unicycive Therapeutics Inc의 상위 5대 주주는 누구인가요?
Unicycive Therapeutics Inc의 상위 5대 주주는 다음과 같습니다: Dr. Sandeep (Steve) Laumas, M.D.
Unicycive Therapeutics Inc(UNCY)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Unicycive Therapeutics Inc의 주식을 보유한 기관은 총 75곳이며, 이들이 보유한 주식의 총 가치는 약 9.56M로 전체 발행 주식의 35.81%를 차지합니다. 이는 2025Q4 대비 450872.00 증가한 수치입니다.